IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,504,559 | +6.2% | 77,261 | -3.9% | 0.01% | +18.2% |
| Q2 2023 | $3,300,166 | +14.8% | 80,433 | 0.0% | 0.01% | +10.0% |
| Q1 2023 | $2,874,675 | -5.4% | 80,433 | 0.0% | 0.01% | -9.1% |
| Q4 2022 | $3,037,954 | -14.6% | 80,433 | 0.0% | 0.01% | -21.4% |
| Q3 2022 | $3,558,000 | +19.5% | 80,433 | 0.0% | 0.01% | +27.3% |
| Q2 2022 | $2,978,000 | -9.5% | 80,433 | -9.5% | 0.01% | +10.0% |
| Q1 2022 | $3,292,000 | +13.6% | 88,879 | -6.7% | 0.01% | +25.0% |
| Q4 2021 | $2,898,000 | -0.9% | 95,234 | +9.2% | 0.01% | -11.1% |
| Q3 2021 | $2,925,000 | -15.5% | 87,216 | +0.5% | 0.01% | -18.2% |
| Q2 2021 | $3,460,000 | -9.4% | 86,745 | +2.1% | 0.01% | -15.4% |
| Q1 2021 | $3,818,000 | -29.8% | 84,923 | -11.7% | 0.01% | -31.6% |
| Q4 2020 | $5,438,000 | +17.4% | 96,182 | -1.5% | 0.02% | +5.6% |
| Q3 2020 | $4,634,000 | -20.5% | 97,657 | -1.2% | 0.02% | -25.0% |
| Q2 2020 | $5,831,000 | +21.7% | 98,892 | -2.4% | 0.02% | +4.3% |
| Q1 2020 | $4,792,000 | -21.7% | 101,352 | 0.0% | 0.02% | 0.0% |
| Q4 2019 | $6,123,000 | -2.3% | 101,352 | -3.1% | 0.02% | -4.2% |
| Q3 2019 | $6,267,000 | -30.4% | 104,600 | -25.3% | 0.02% | -27.3% |
| Q2 2019 | $8,998,000 | -20.8% | 140,000 | 0.0% | 0.03% | -23.3% |
| Q1 2019 | $11,364,000 | +110.2% | 140,000 | +40.0% | 0.04% | +87.0% |
| Q4 2018 | $5,406,000 | +4.8% | 100,000 | 0.0% | 0.02% | +21.1% |
| Q3 2018 | $5,158,000 | +23.8% | 100,000 | 0.0% | 0.02% | +18.8% |
| Q2 2018 | $4,167,000 | -5.5% | 100,000 | 0.0% | 0.02% | -5.9% |
| Q1 2018 | $4,408,000 | -12.4% | 100,000 | 0.0% | 0.02% | -10.5% |
| Q4 2017 | $5,030,000 | -0.8% | 100,000 | 0.0% | 0.02% | -5.0% |
| Q3 2017 | $5,070,000 | -0.3% | 100,000 | 0.0% | 0.02% | -4.8% |
| Q2 2017 | $5,087,000 | +26.5% | 100,000 | 0.0% | 0.02% | +23.5% |
| Q1 2017 | $4,020,000 | -16.0% | 100,000 | 0.0% | 0.02% | -19.0% |
| Q4 2016 | $4,783,000 | +30.5% | 100,000 | 0.0% | 0.02% | +31.2% |
| Q3 2016 | $3,664,000 | +57.3% | 100,000 | 0.0% | 0.02% | +45.5% |
| Q2 2016 | $2,329,000 | -42.5% | 100,000 | 0.0% | 0.01% | -38.9% |
| Q1 2016 | $4,050,000 | -67.3% | 100,000 | -50.0% | 0.02% | -30.8% |
| Q4 2015 | $12,386,000 | – | 200,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |